רנקסה 1000 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

RANOLAZINE 1000 MG

Tilgjengelig fra:

NEOPHARM LTD

ATC-kode:

C01EB18

Legemiddelform:

TABLETS EXTENDED RELEASE

Administreringsrute:

PER OS

Produsert av:

CV THERAPEUTICS INC, USA

Terapeutisk gruppe:

RANOLAZINE

Indikasjoner:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Autorisasjon dato:

2010-10-01